Form 4 for CRL Charles River Laboratories
Accepted 2026-05-28 16:24:53 ET · period of report 2026-05-26 · accession 0001100682-26-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-28 16:24 | 2026-05-26+ | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $158.76 | -428 | 27.0K | -2% | -$67.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | F | D | 243 | $160.30 | 27,205 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-27 | F | D | 185 | $156.73 | 27,020 | D | — | — |